USA: Thank you chair, we have had three sessions of informals and believe we have completed a review of the preamble so should be able to get through that but may need time or the operative paragraphs. Chair: We will now move through L7, is there any comments? Title approved. PP1 Australia: originally this pp …
India
Plenary: Item 10. Implementation of the Political Declaration and Plan of Action on International Cooperation towards an Integrated and Balanced Strategy to Counter the World Drug Problem
Chair: In the Ministerial Declaration, Member States committed to reporting on the 2009 document and 2016 document. Consideration of this item during this regular session enables us to consider this matter further, beyond last week’s debates. The Secretariat has made available reports on the situation of drug abuse and trafficking. Also before the Commission is …
Plenary: Item 9. Implementation of the international drug control treaties
European Union: the EU and its member states are committed to the implementation of the three un drug conventions. The EU and its member states welcome the opportunity to reflect on drug control and human rights. Successful drug control intervention needs to be evidence-based approached in line with the drug control convention. The protection of human …
Plenary: Item 4. General debate of the ministerial segment (cont…)
Brazil: We would like to associate ourselves with Egypt’s statement on behalf of the G77. Brazil welcomes the ministerial declaration renewing our global commitment to counter the WDP. As we reinforce international cooperation, we create an inducive environment. If we are to reach the strongest links of the drug market, we have to ensure criminals …
CND Intersessional Meeting, 8 November 2018: Taking stock of the implementation of the commitments made to jointly address and counter the world drug problem
Chair: We focus now on the 2019 target date. (panel) Statistical Committee / Angela Me: Our five targets are, as you know, eliminate or reduce significantly and measurably (1) illicit cultivation of opium, coca and cannabis (2) illicit demand of drugs and drug-related health and social risks (3) illicit market of synthetic drugs (4) diversion …
CND intersessional meeting, 26 september 2018: Access to controlled substances for medical and scientific purposes
Chair: Good Morning. Let’s start right away with the presentations and take advantage of the opportunity to conduct interactive sessions. PANEL: Dr. Gilberto Gerra, Chief of Drug Prevention and Health Branch, UNODC: Access to controlled drugs for medical purposes while preventing misuse and diversion. For long time this aspect was not paid attention so now …